http://www.fiercebiotech.com/story/niche-cancer-drugs-highli...The new school also includes sticker shock for payers. Pfizer's Xalkori (crizotinib) will arrive at a cost of $115,000 a year, with some built-in protections for the uninsured and underinsured. The melanoma drug Zelboraf (vemurafenib) is priced at $56,400 for 6 months of treatment.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra